![[background image]](https://cdn.prod.website-files.com/image-generation-assets/538f97b7-58ea-4bee-9687-9b45d139d0d8.avif)
Expert guidance on regulatory pathways for medical devices. Streamline your market entry and ensure compliance every step of the way.
The U.S. Food and Drug Administration regulates medical devices through a risk-based classification system that determines the applicable premarket submission pathway. Based on the device’s intended use and technological characteristics, manufacturers may be required to submit a Premarket Notification (510(k)), De Novo request, or Premarket Approval application. Regulatory obligations also include compliance with FDA quality system requirements, labeling controls, and post-market surveillance throughout the product lifecycle.
MediNova supports medical device manufacturers with FDA regulatory submissions tailored to device classification and intended use. Our services include regulatory pathway assessment, preparation and submission of 510(k), De Novo, and PMA applications, and development of comprehensive technical documentation aligned with FDA requirements. We participate in FDA pre-submission meetings, prepare and manage responses to FDA reviewer questions and requests for additional information, and support ongoing regulatory interactions through to clearance or approval.
We also assist with implementation and auditing of FDA QMSR-aligned quality management systems to support inspection readiness and post-market compliance.
The Therapeutic Goods Administration regulates medical devices in Australia in accordance with their classification, intended purpose, and risk profile. Inclusion in the Australian Register of Therapeutic Goods is required prior to supply, supported by conformity assessment evidence that may rely on Australian conformity assessment procedures or recognised overseas certifications. Regulatory responsibilities extend to sponsor obligations, ongoing compliance monitoring, and post-market reporting activities.
MediNova provides end-to-end support for Australian regulatory submissions, from device classification through inclusion in the Australian Register of Therapeutic Goods. We assist with ARTG application strategy, technical file preparation, conformity assessment submission, and alignment of overseas approvals where applicable.
Our services extend to sponsor support, post-market compliance activities, and regulatory maintenance to ensure continued compliance with Australian regulatory requirements.
The European Union Medical Device Regulation establishes a comprehensive regulatory framework based on device classification, intended use, and clinical risk. Manufacturers are required to prepare detailed technical documentation and, where applicable, undergo conformity assessment by a designated Notified Body. The regulation places increased emphasis on clinical evaluation, post-market surveillance, and lifecycle oversight to ensure continued compliance and patient safety
MediNova supports manufacturers in navigating the European Union Medical Device Regulation through tailored submission strategies based on device classification and risk. Our services include preparation and review of MDR technical documentation, clinical evaluation support, and coordination with Notified Bodies where required. We also assist with post-market surveillance planning, regulatory gap assessments, and lifecycle compliance to support successful EU market access and ongoing conformity.
The Medicines and Healthcare products Regulatory Agency regulates medical devices placed on the Great Britain market under a risk-based framework aligned to device classification and intended purpose. Depending on the device type, conformity assessment and UKCA marking may be required prior to market access. Manufacturers and UK Responsible Persons are responsible for maintaining regulatory compliance, managing vigilance reporting, and ensuring ongoing device safety and performanc
MediNova assists manufacturers with regulatory submissions for the Great Britain market, supporting UKCA conformity assessment activities aligned to device classification and intended purpose. We provide guidance on submission strategy, technical documentation readiness, and UK Responsible Person obligations where applicable. Our services include support with regulatory change management, vigilance reporting, and ongoing compliance to maintain market access in the UK.
Speak with a regulatory specialist.
